Nike Surprises Wall Street With Strong Q1 Results
Sneaker giant’s turnaround plan shows progress despite tariffs and brand challenges Nike (NKE) delivered better-than-expected fiscal first-quarter results on Tuesday, ...
Tag: Earnings
Micron Projects Strong Revenue on AI-Driven Chip Demand
Memory maker forecasts above-estimate sales as artificial intelligence fuels growth Micron Technology (MU) delivered an upbeat forecast for its fiscal ...
Stocks Slip After Weak Jobs Report as Broadcom, Lululemon Drive Market Moves
Broadcom jumps on $10B AI customer; Lululemon sinks on weak U.S. sales and tariff costs U.S. equities turned lower at ...
Goldman Sachs Bets $1 Billion on T. Rowe Price in Private Markets Push
Partnership aims to bring alternative investments to retirement savers and wealthy clients Goldman Sachs Group (GS) is making a rare ...
Nvidia Surpasses Earnings Expectations as AI Demand Fuels Growth
Chipmaker Projects Strong Outlook Despite China Export Restrictions Nvidia reported quarterly earnings on Wednesday that exceeded Wall Street expectations, highlighting ...
KULR Technology Group Reports Record Q2 Revenue and Expands Bitcoin Treasury Holdings
Frontier technology firm posts strong top-line growth, boosts BTC portfolio, and advances R&D in energy systems and robotics KULR Technology ...
Cava Shares Plunge as Chain Cuts Same-Store Sales Outlook
Flat traffic and post–menu launch slowdown weigh on performance despite revenue growth Cava (CAVA) shares tumbled 20% in extended trading ...
LegalZoom Soars as Bank of America Upgrades Rating on AI Momentum and Subscription Growth
BofA sees LegalZoom’s strategic shift toward subscriptions and AI partnerships as key drivers of long-term value LegalZoom (LZ) shares jumped ...
Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations
Cosmetics giant sees 30% profit drop as China duties weigh on bottom line, even as revenue and product innovation remain ...
Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast
Telehealth company maintains 2025 outlook, expands beyond GLP-1 offerings amid regulatory and partnership setbacks Hims & Hers Health (HIMS) stock ...
